Cargando…
Exploring the mechanism of cordycepin combined with doxorubicin in treating glioblastoma based on network pharmacology and biological verification
BACKGROUND: Glioblastoma is the most common and fatal primary malignant tumor in the central nervous system, and the prognosis is poor. Currently, there are no effective treatments for glioblastoma. Cordycepin is a natural active substance with significant anticancer activity and doxorubicin is a br...
Autores principales: | Chen, Jing, Zhuang, Yuan-Dong, Zhang, Qiang, Liu, Shuang, Zhuang, Bing-Bo, Wang, Chun-Hua, Liang, Ri-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855715/ https://www.ncbi.nlm.nih.gov/pubmed/35186504 http://dx.doi.org/10.7717/peerj.12942 |
Ejemplares similares
-
Utilizing network pharmacology and molecular docking to explore the underlying mechanism of Guizhi Fuling Wan in treating endometriosis
por: Wang, Haoxian, et al.
Publicado: (2021) -
Computational analysis and verification of molecular genetic targets for glioblastoma
por: Xue, Liang, et al.
Publicado: (2020) -
Uncovering the mechanism of Ge-Gen-Qin-Lian decoction for treating ulcerative colitis based on network pharmacology and molecular docking verification
por: Xu, Lin, et al.
Publicado: (2021) -
Regulatory mechanism of Scutellaria baicalensis Georgi on bone cancer pain based on network pharmacology and experimental verification
por: Wang, Aitao, et al.
Publicado: (2022) -
EXOSC10 is a novel hepatocellular carcinoma prognostic biomarker: a comprehensive bioinformatics analysis and experiment verification
por: Meng, Zhi-Yong, et al.
Publicado: (2023)